Related Experiment Videos
Immunosuppressive drug use in pregnancy
1Johns Hopkins University School of Medicine, 1830 E. Monument Street, Suite 7500, Baltimore, MD 21205, USA.
Autoimmunity
|May 27, 2003
Summary
Immunosuppressive drugs are sometimes needed during pregnancy for conditions like lupus to protect mothers and ensure successful pregnancies. This review focuses on commonly used medications, excluding those unsafe for pregnant patients.
Area of Science:
- Rheumatology
- Maternal-Fetal Medicine
- Clinical Pharmacology
Background:
- Immunosuppressive drug use in pregnancy presents a complex clinical challenge.
- Certain autoimmune conditions necessitate immunosuppression for maternal and fetal well-being.
- Systemic lupus erythematosus (SLE), vasculitis, and antiphospholipid antibody syndrome are key indications.
Purpose of the Study:
- To review commonly used immunosuppressive drugs during pregnancy.
- To emphasize available human data for drug safety and efficacy.
- To provide guidance on managing immunosuppression in high-risk pregnancies.
Main Methods:
- Literature review of immunosuppressive medications.
- Focus on human pregnancy data.
- Exclusion of methotrexate and leflunomide due to teratogenicity.
Main Results:
- Several immunosuppressive drugs are utilized in pregnant patients with connective tissue diseases.
- Human data guides the selection and management of these medications.
- Specific drug profiles and safety considerations are discussed.
Conclusions:
- Careful selection and monitoring of immunosuppressive drugs are crucial in pregnancy.
- Risk-benefit assessment is paramount for maternal and fetal outcomes.
- Avoidance of specific agents like methotrexate and leflunomide is critical.